These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 15530990)
1. Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors. Pouget C; Yahiaoui S; Fagnere C; Habrioux G; Chulia AJ Bioorg Chem; 2004 Dec; 32(6):494-503. PubMed ID: 15530990 [TBL] [Abstract][Full Text] [Related]
2. Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors. Yahiaoui S; Pouget C; Buxeraud J; Chulia AJ; Fagnère C Eur J Med Chem; 2011 Jun; 46(6):2541-5. PubMed ID: 21497425 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors. Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607 [TBL] [Abstract][Full Text] [Related]
4. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation. Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of 4-imidazolylflavans as new leads for aromatase inhibition. Pouget C; Fagnere C; Basly JP; Habrioux G; Chulia AJ Bioorg Med Chem Lett; 2002 Oct; 12(20):2859-61. PubMed ID: 12270163 [TBL] [Abstract][Full Text] [Related]
6. Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation. Gobbi S; Zimmer C; Belluti F; Rampa A; Hartmann RW; Recanatini M; Bisi A J Med Chem; 2010 Jul; 53(14):5347-51. PubMed ID: 20568782 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors. Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of new A,D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation. Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA J Med Chem; 2005 Oct; 48(20):6379-85. PubMed ID: 16190763 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of (+/-)-abyssinone II and its analogues as aromatase inhibitors for chemoprevention of breast cancer. Maiti A; Cuendet M; Croy VL; Endringer DC; Pezzuto JM; Cushman M J Med Chem; 2007 Jun; 50(12):2799-806. PubMed ID: 17511439 [TBL] [Abstract][Full Text] [Related]
10. Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts--a comparative study. van Meeuwen JA; Nijmeijer S; Mutarapat T; Ruchirawat S; de Jong PC; Piersma AH; van den Berg M Toxicol Appl Pharmacol; 2008 May; 228(3):269-76. PubMed ID: 18201740 [TBL] [Abstract][Full Text] [Related]
11. New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation. Varela C; Tavares da Silva EJ; Amaral C; Correia da Silva G; Baptista T; Alcaro S; Costa G; Carvalho RA; Teixeira NA; Roleira FM J Med Chem; 2012 Apr; 55(8):3992-4002. PubMed ID: 22475216 [TBL] [Abstract][Full Text] [Related]
12. Combining computational and biochemical studies for a rationale on the anti-aromatase activity of natural polyphenols. Neves MA; Dinis TC; Colombo G; Sá e Melo ML ChemMedChem; 2007 Dec; 2(12):1750-62. PubMed ID: 17910019 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of azole isoflavone inhibitors of aromatase. Hackett JC; Kim YW; Su B; Brueggemeier RW Bioorg Med Chem; 2005 Jun; 13(12):4063-70. PubMed ID: 15911319 [TBL] [Abstract][Full Text] [Related]
14. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells. Belosay A; Brodie AM; Njar VC Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897 [TBL] [Abstract][Full Text] [Related]
15. Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme. Gobbi S; Cavalli A; Rampa A; Belluti F; Piazzi L; Paluszcak A; Hartmann RW; Recanatini M; Bisi A J Med Chem; 2006 Jul; 49(15):4777-80. PubMed ID: 16854084 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of benzoxazolinonic imidazoles and derivatives as non-steroidal aromatase inhibitors. Nativelle-Serpentini C; Moslemi S; Yous S; Park CH; Lesieur D; Sourdaine P; Séralini GE J Enzyme Inhib Med Chem; 2004 Apr; 19(2):119-27. PubMed ID: 15449726 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones. Kim YW; Hackett JC; Brueggemeier RW J Med Chem; 2004 Jul; 47(16):4032-40. PubMed ID: 15267241 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and aromatase inhibitory activities of novel indole-imidazole derivatives. Wang R; Shi HF; Zhao JF; He YP; Zhang HB; Liu JP Bioorg Med Chem Lett; 2013 Mar; 23(6):1760-2. PubMed ID: 23403081 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of benzimidazole and imidazole compounds as potential aromatase inhibitors. Hida F; Robert J; Luu-Duc C Farmaco; 1994; 49(7-8):489-92. PubMed ID: 7945714 [TBL] [Abstract][Full Text] [Related]
20. Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity. Wood PM; Woo LW; Labrosse JR; Trusselle MN; Abbate S; Longhi G; Castiglioni E; Lebon F; Purohit A; Reed MJ; Potter BV J Med Chem; 2008 Jul; 51(14):4226-38. PubMed ID: 18590272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]